Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/scineuro-initiates-phase-1-clinical-trial-with-snp318-a-novel-lp-pla2-inhibitor-targeting-neurodegenerative-and-inflammatory-diseases-301795215.html
https://www.prnewswire.com/news-releases/scineuro-pharmaceuticals-announces-the-appointment-of-guojun-bu-phd-as-chief-scientific-officer-and-provides-update-on-pipeline-of-novel-cns-therapeutics-301692283.html
https://www.prnewswire.com/news-releases/scineuro-pharmaceuticals-announces-a-license-and-option-agreement-with-gsk-to-progress-development-of-novel-therapies-for-cns-diseases-301557923.html